SlideShare a Scribd company logo
Low Risk ED Chest Pain Patients: Is
 Computed Tomography Coronary
   Angiography the Holy Grail?




          Ezra A. Amsterdam
               UC Davis
Conflicts
My only conflicts are inner conflicts and
     I decline to reveal them!
Evaluation of Low Risk Patients
Presenting to ED with Chest Pain

•   Magnitude of the problem
•   Low and intermediate risk
•   “Confirmatory” tests
•   CPU and accelerated diagnostic protocols
Magnitude of the Problem

• 8,000,000 ED visits/yr in the U.S. for chest pain
• Minority of CP visits are for CVD
  – Largest single cause: somatoform disorders
Spectrum of Patients Presenting
 to ED with Chest Pain (8,000,000/yr)
    STEMI                             <5%
      Reperfusion



   Non-STE ACS                        20-30%
      Antiischemic Rx


   Low Risk Chest Pain                65-75%
      Accelerated Dx Protocol (ADP)
Inappropriate Discharges
 Missed ACS (2.3%, Pope, NEJM, 2000)
 Medicolegal liability


Inappropriate Admissions
 Inefficient resource utilization
 Major expense to system
Evaluation of Low Risk Patients
Presenting to ED with Chest Pain

• Goal is to exclude ACS
• Not to exclude CAD!
• We treat patients, not anatomy
Evaluation of Low Risk Patients
Presenting to ED with Chest Pain

•   Magnitude of the problem
•   Low and intermediate risk
•   “Confirmatory” tests
•   CPU and accelerated diagnostic protocols
Low Risk in Patients Presenting
  to the ED with Chest Pain

<5% Probability of ACS
 –History – Typical or atypical CP
 –Exam – Clinically stable
 –ECG     – Normal (or unchanged)
 (Negative injury markers greatly risk)
 Intermediate risk: >65 yo, CAD, DM. CRI
Low Risk Is Not No Risk

“Confirmatory” test to
 further reduce risk

Nothing is 0%, Nothing is 100%
Evaluation of Low Risk Patients
•   Magnitude of the problem
•   Low and intermediate risk
•   Confirmatory tests
•   CPU and accelerated diagnostic protocols
Multimarker




BMIPP
“Confirmatory” Tests

• One size does not fit all

• Multiple approaches to the problem


• Test selection based on institutional
  expertise, resources, preference
Scientific Statement of the American Heart Association
“Confirmatory” Tests
• Functional                 Neg. Predictive Value
  – Treadmill Ex                  >99%
  – MPS(sestamibi, stress)        >99%
  – Stress Echo                   ~95%

• Anatomic
  – CTCA                           >99%
  – (MRI)

• No Test?                        >99%
Evaluation of Low Risk Patients
•   Magnitude of the problem
•   Low and intermediate risk
•   Confirmatory tests
•   CPU and accelerated diagnostic protocols
Chest Pain Unit
• Physical structure
• “Virtual” Unit (UCDMC)
 –Accelerated diagnostic protocol (ADP)
   • Serial ECGs
   • cardiac injury markers
   • LOS 2-6 hrs
Accelerated Diagnostic Protocol
              ED
        Clinically Stable
      Negative ECG/Markers

             Low Risk


             CPU
Accelerated Diagnostic Protocol
                 CPU
     Serial ECGs, Markers (1-2 sets)



   To exclude ischemia/necrosis at rest
Accelerated Diagnostic Protocol
                CPU
    Serial ECGs, Markers (1-2 sets)

               if negative

     “Confirmatory” test
Accelerated Diagnostic Protocol
                      CPU
    Serial ECGs, Markers (1-2 sets)

                    if negative

        Confirmatory test

     To exclude inducible ischemia or anatomic CAD
Accelerated Diagnostic Protocol
                    CPU
    Serial ECGs, Markers (1-2 sets)

                   if negative

        Confirmatory test
          if negative     if positive

    Discharge                    Admit
     w/follow-up
UCDMC CPU
• 17 years, >6,000 patients
  – Elderly/young, M/F, +/- CAD, antianginal drugs, DM
  – TIMI risk score not applied in CPU patients


• ACC/AHA guidelines
  – ETT
     • If ECG WNL and patient can exercise
     • 1/3 patients require a different test


• Preferred initial test at many centers - MPS,
  CTCA based on expertise, resources
ADP in Low Risk Women
            Presenting with CP
•   N = 371
•   <50 yo, no DM/smoking,
•   ED ECG normal, clinically stable, neg. markers
•   ETT = 240, Stress imaging = 20, no confirmatory test = 111
•   Negative CPU evaluation in all patients, all directly discharged

• 5 yr follow-up: 0 cardiac events
• Conclusion: All CP patients do not
  require confirmatory testing
No Confirmatory Test
• If ECG, Troponin Negative:
• UC Davis
  – 40% of pts discharged without test, LOS <2 hr
  – NPV 100% at 1 year
• Than (Lancet, JACC) 2012
  – No Test, LOS 2 hr
    • TIMI score 0, ECG neg, hs-cTi neg at 0 and 2 hrs.
  – NPV >99% at 30 days
•Age ≥ 65 y
                        TIMI Risk Score for
  • Age ≥65y
  •≥ 3 CAD Risk Factors
  •≥3CAD RFs
  •Prior Stenosis > 50%
  •CAD
                           UA/NSTEMI
  •ST deviation
  •ST
       deviation                                   Antman et al JAMA 284: 835, 2000
  •≥ Anginal events ≤ 24 h
  •≥2 angina/24 h
  •ASAin last 7 7 d.
  •ASA
         in last days
  •Elev Cardiac Markers
  •↑ Markers
DI/MI/Urg Revasc




                   50                                          40.9
                   40                              26.2
                   30                       19.9
       (%)




                   20         8.3    13.2
                        4.7
                   10
                    0
                        0/1    2      3      4      5            6/7
                               Number of Risk Factors
% Population 4.3              17.3   32.0   29.3   13.0          3.4
“Confirmatory” Tests
• Functional             Neg. Predictive Value
  – Treadmill Ex             >99%
  – MPS(sestamibi, stress)   >99%
  – Stress Echo              ~95%

• Anatomic
  –CTCA                      >99%
• No Test                     >99%
ROMICAT

               ED ETT – 99% NPV
               Discharge in <6 hr.
               Cost $1200 (UCDMC)

                38% of patients did not qualify for CTCA




Schlett et al, JACCi 2011;4:461
CTA in the ED
•   12 studies (2005-2012)
•   N = 5865 pts, 30-81 y.o.
•   NPV 96-100% (ED and >1 yr)
•   PPV 13-87%
•   LOS 7-21 hrs
•   Radiation 5-18 mSv
Radiation
• 10-20 mSv exposure = 1 new Ca for
  every 500-1000 scans
• US National Research Council on
  ionizing radiation (2005)
Revascularization after CTA
    for Low Risk ED CP Patients
    (Positive Predictive Value 13-87%)

           Std Care (%)      CTA (%)
Goldstein    1.0              5.0
CT-STAT      2.4              3.6
Litt         1.3              2.7
ROMICAT-II   4.2              6.4
CTA in ED – Exclusions
                                              CTA   ETT
CAD- h/o MI, PCI or CABG                      YES   NO
CKD                                           YES   NO
COPD                                          YES   NO
Allergy to contrast/ shellfish                YES   NO
> 6 hrs since presentation to ED              YES   NO
BMI ≥39 kg/m 2                                YES   NO
Metformin therapy                             YES   NO
Contraindication to β-blocker                 YES   NO
Inability to hold breath                      YES   NO
Pregnancy                                     YES   NO
CT imaging within past 48 hours               YES   NO
Normal CTA/cor angiography in previous year   YES   NO
Cocaine use within past 48 hours              YES   NO
Radiographic abnormalities                    YES   NO
HR >90 bpm**                                  YES   NO
CTA in ED

 Exclusions
 12% 50%
   46%   52%
(More than half of studies do not include % exclusions)

     Standard of Care?
CTA for Chest Pain Patients in
            the ED


The gold standard


      OR…
       The Midas touch?
Summary
• Low/interm risk - ID on presentation

• Goal – Exclude ACS (not exclude CAD)

• Evaluation - ADP, Confirmatory test

• All patients do not require confirmatory test

• CTCA – Selected patients only!

More Related Content

What's hot

Dislipemia. iPCSK9
Dislipemia. iPCSK9Dislipemia. iPCSK9
ACT
ACTACT
Pegasus
PegasusPegasus
Cohen MG 201305
Cohen MG 201305Cohen MG 201305
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen testKoutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
International Chair on Interventional Cardiology and Transradial Approach
 
Saito S DRAGON trial
Saito S DRAGON trialSaito S DRAGON trial
2014session5 3
2014session5 32014session5 3
2014session5 3
acvq
 
CT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress TestCT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress Test
ahvc0858
 
Fernando alfonso isr sec-2015
Fernando alfonso isr sec-2015Fernando alfonso isr sec-2015
Dr. Sharma 1
Dr. Sharma 1Dr. Sharma 1
Stroke guidelines
Stroke guidelinesStroke guidelines
Stroke guidelines
Ahmed Koriesh
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1
Mohammed Adel
 
CTO: How to define success
CTO: How to define successCTO: How to define success
CTO: How to define success
Euro CTO Club
 
Acs focus on dapt
Acs focus on daptAcs focus on dapt
Acs focus on dapt
magdy elmasry
 
Antiplatelet agents in acute coronary syndrome
Antiplatelet agents in acute coronary syndromeAntiplatelet agents in acute coronary syndrome
Antiplatelet agents in acute coronary syndrome
salahabusin
 
Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...
Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...
Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...
Sociedad Española de Cardiología
 
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Sergio Pinski
 
Metabolomic Profile of Human Myocardial Ischemia by NMR Spectroscopy of Perip...
Metabolomic Profile of HumanMyocardial Ischemia by NMR Spectroscopy of Perip...Metabolomic Profile of HumanMyocardial Ischemia by NMR Spectroscopy of Perip...
Metabolomic Profile of Human Myocardial Ischemia by NMR Spectroscopy of Perip...
Nagi Abdalla
 
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elev...
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elev...Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elev...
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elev...
vaibhavyawalkar
 
Plato trial
Plato trialPlato trial
Plato trial
Habibur Rahaman
 

What's hot (20)

Dislipemia. iPCSK9
Dislipemia. iPCSK9Dislipemia. iPCSK9
Dislipemia. iPCSK9
 
ACT
ACTACT
ACT
 
Pegasus
PegasusPegasus
Pegasus
 
Cohen MG 201305
Cohen MG 201305Cohen MG 201305
Cohen MG 201305
 
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen testKoutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
 
Saito S DRAGON trial
Saito S DRAGON trialSaito S DRAGON trial
Saito S DRAGON trial
 
2014session5 3
2014session5 32014session5 3
2014session5 3
 
CT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress TestCT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress Test
 
Fernando alfonso isr sec-2015
Fernando alfonso isr sec-2015Fernando alfonso isr sec-2015
Fernando alfonso isr sec-2015
 
Dr. Sharma 1
Dr. Sharma 1Dr. Sharma 1
Dr. Sharma 1
 
Stroke guidelines
Stroke guidelinesStroke guidelines
Stroke guidelines
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1
 
CTO: How to define success
CTO: How to define successCTO: How to define success
CTO: How to define success
 
Acs focus on dapt
Acs focus on daptAcs focus on dapt
Acs focus on dapt
 
Antiplatelet agents in acute coronary syndrome
Antiplatelet agents in acute coronary syndromeAntiplatelet agents in acute coronary syndrome
Antiplatelet agents in acute coronary syndrome
 
Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...
Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...
Pacientes con FA que sufren un SCA y son sometidos a intervención coronaria p...
 
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
 
Metabolomic Profile of Human Myocardial Ischemia by NMR Spectroscopy of Perip...
Metabolomic Profile of HumanMyocardial Ischemia by NMR Spectroscopy of Perip...Metabolomic Profile of HumanMyocardial Ischemia by NMR Spectroscopy of Perip...
Metabolomic Profile of Human Myocardial Ischemia by NMR Spectroscopy of Perip...
 
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elev...
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elev...Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elev...
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elev...
 
Plato trial
Plato trialPlato trial
Plato trial
 

Viewers also liked

125 ct based characterization
125 ct based characterization125 ct based characterization
125 ct based characterization
SHAPE Society
 
182 non invasive coronary angiography
182 non invasive coronary angiography182 non invasive coronary angiography
182 non invasive coronary angiography
SHAPE Society
 
Ct coronary angiography gptalk
Ct coronary angiography gptalk Ct coronary angiography gptalk
Ct coronary angiography gptalk
alistair Begg
 
diagnostic procedures of cardiovascular system
diagnostic procedures of cardiovascular systemdiagnostic procedures of cardiovascular system
diagnostic procedures of cardiovascular system
AIIMS, Rishikesh
 
CT Coronary Angiography (CTCA)
CT Coronary Angiography (CTCA)CT Coronary Angiography (CTCA)
CT Coronary Angiography (CTCA)
SCGH ED CME
 
Cardiac CT
Cardiac CT Cardiac CT
Cardiac CT
Sudil Paudyal
 

Viewers also liked (6)

125 ct based characterization
125 ct based characterization125 ct based characterization
125 ct based characterization
 
182 non invasive coronary angiography
182 non invasive coronary angiography182 non invasive coronary angiography
182 non invasive coronary angiography
 
Ct coronary angiography gptalk
Ct coronary angiography gptalk Ct coronary angiography gptalk
Ct coronary angiography gptalk
 
diagnostic procedures of cardiovascular system
diagnostic procedures of cardiovascular systemdiagnostic procedures of cardiovascular system
diagnostic procedures of cardiovascular system
 
CT Coronary Angiography (CTCA)
CT Coronary Angiography (CTCA)CT Coronary Angiography (CTCA)
CT Coronary Angiography (CTCA)
 
Cardiac CT
Cardiac CT Cardiac CT
Cardiac CT
 

Similar to Dr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular Symposium

Non Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptxNon Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptx
hospital
 
TIA risk stratification
TIA risk stratificationTIA risk stratification
TIA risk stratification
SCGH ED CME
 
076 cardiac magnetic resonance imaging
076 cardiac magnetic resonance imaging076 cardiac magnetic resonance imaging
076 cardiac magnetic resonance imaging
SHAPE Society
 
Cardiac Pet Power Point
Cardiac Pet Power PointCardiac Pet Power Point
Cardiac Pet Power Point
ELITE IMAGING
 
Dr. Jose Luis Zamorano. Evolución no invasiva de la enfermedad aterosclerótica
Dr. Jose Luis Zamorano. Evolución no invasiva de la enfermedad ateroscleróticaDr. Jose Luis Zamorano. Evolución no invasiva de la enfermedad aterosclerótica
Dr. Jose Luis Zamorano. Evolución no invasiva de la enfermedad aterosclerótica
Sociedad Española de Cardiología
 
Approach to chest pain
Approach to chest painApproach to chest pain
Approach to chest pain
RLHEDFY2teaching
 
What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?
kellyam18
 
Improving outcomes of patients on AAA surveillance Adam Haque
Improving outcomes of patients on AAA surveillance Adam HaqueImproving outcomes of patients on AAA surveillance Adam Haque
Improving outcomes of patients on AAA surveillance Adam Haque
PHEScreening
 
Management of Carotid Artery Stenosis - Evidence and guidelines
Management of Carotid Artery Stenosis - Evidence and guidelinesManagement of Carotid Artery Stenosis - Evidence and guidelines
Management of Carotid Artery Stenosis - Evidence and guidelines
Satyam Rajvanshi
 
Aha lbct
Aha lbctAha lbct
AHA: LBCT
AHA: LBCTAHA: LBCT
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
ahvc0858
 
Anesthesia for elderly
Anesthesia for elderlyAnesthesia for elderly
Anesthesia for elderly
sky2024star
 
Jose r lopez minguez novedades cierre laa
Jose r lopez minguez novedades cierre laaJose r lopez minguez novedades cierre laa
Jose r lopez minguez novedades cierre laa
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Recent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysisRecent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysis
Dr Vipul Gupta
 
Thorax cardio coeur heart evaluation asymptomatic smoker p douek
Thorax cardio coeur heart evaluation asymptomatic smoker p douekThorax cardio coeur heart evaluation asymptomatic smoker p douek
Thorax cardio coeur heart evaluation asymptomatic smoker p douek
JFIM
 
Adrenal Incidentalomas
Adrenal IncidentalomasAdrenal Incidentalomas
Adrenal Incidentalomas
PeninsulaEndocrine
 
Coronary ct angiography in the er
Coronary ct angiography in the erCoronary ct angiography in the er
Coronary ct angiography in the er
Stephen Fleet
 
Deep dive ACS.pptx
Deep dive ACS.pptxDeep dive ACS.pptx
Deep dive ACS.pptx
OfferArcherZul
 
Emergency ct-is it being overused dr.amarnath
Emergency ct-is it being overused dr.amarnathEmergency ct-is it being overused dr.amarnath
Emergency ct-is it being overused dr.amarnath
Teleradiology Solutions
 

Similar to Dr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular Symposium (20)

Non Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptxNon Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptx
 
TIA risk stratification
TIA risk stratificationTIA risk stratification
TIA risk stratification
 
076 cardiac magnetic resonance imaging
076 cardiac magnetic resonance imaging076 cardiac magnetic resonance imaging
076 cardiac magnetic resonance imaging
 
Cardiac Pet Power Point
Cardiac Pet Power PointCardiac Pet Power Point
Cardiac Pet Power Point
 
Dr. Jose Luis Zamorano. Evolución no invasiva de la enfermedad aterosclerótica
Dr. Jose Luis Zamorano. Evolución no invasiva de la enfermedad ateroscleróticaDr. Jose Luis Zamorano. Evolución no invasiva de la enfermedad aterosclerótica
Dr. Jose Luis Zamorano. Evolución no invasiva de la enfermedad aterosclerótica
 
Approach to chest pain
Approach to chest painApproach to chest pain
Approach to chest pain
 
What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?
 
Improving outcomes of patients on AAA surveillance Adam Haque
Improving outcomes of patients on AAA surveillance Adam HaqueImproving outcomes of patients on AAA surveillance Adam Haque
Improving outcomes of patients on AAA surveillance Adam Haque
 
Management of Carotid Artery Stenosis - Evidence and guidelines
Management of Carotid Artery Stenosis - Evidence and guidelinesManagement of Carotid Artery Stenosis - Evidence and guidelines
Management of Carotid Artery Stenosis - Evidence and guidelines
 
Aha lbct
Aha lbctAha lbct
Aha lbct
 
AHA: LBCT
AHA: LBCTAHA: LBCT
AHA: LBCT
 
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
 
Anesthesia for elderly
Anesthesia for elderlyAnesthesia for elderly
Anesthesia for elderly
 
Jose r lopez minguez novedades cierre laa
Jose r lopez minguez novedades cierre laaJose r lopez minguez novedades cierre laa
Jose r lopez minguez novedades cierre laa
 
Recent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysisRecent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysis
 
Thorax cardio coeur heart evaluation asymptomatic smoker p douek
Thorax cardio coeur heart evaluation asymptomatic smoker p douekThorax cardio coeur heart evaluation asymptomatic smoker p douek
Thorax cardio coeur heart evaluation asymptomatic smoker p douek
 
Adrenal Incidentalomas
Adrenal IncidentalomasAdrenal Incidentalomas
Adrenal Incidentalomas
 
Coronary ct angiography in the er
Coronary ct angiography in the erCoronary ct angiography in the er
Coronary ct angiography in the er
 
Deep dive ACS.pptx
Deep dive ACS.pptxDeep dive ACS.pptx
Deep dive ACS.pptx
 
Emergency ct-is it being overused dr.amarnath
Emergency ct-is it being overused dr.amarnathEmergency ct-is it being overused dr.amarnath
Emergency ct-is it being overused dr.amarnath
 

Dr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular Symposium

  • 1. Low Risk ED Chest Pain Patients: Is Computed Tomography Coronary Angiography the Holy Grail? Ezra A. Amsterdam UC Davis
  • 2. Conflicts My only conflicts are inner conflicts and I decline to reveal them!
  • 3. Evaluation of Low Risk Patients Presenting to ED with Chest Pain • Magnitude of the problem • Low and intermediate risk • “Confirmatory” tests • CPU and accelerated diagnostic protocols
  • 4. Magnitude of the Problem • 8,000,000 ED visits/yr in the U.S. for chest pain • Minority of CP visits are for CVD – Largest single cause: somatoform disorders
  • 5. Spectrum of Patients Presenting to ED with Chest Pain (8,000,000/yr) STEMI <5% Reperfusion Non-STE ACS 20-30% Antiischemic Rx Low Risk Chest Pain 65-75% Accelerated Dx Protocol (ADP)
  • 6. Inappropriate Discharges Missed ACS (2.3%, Pope, NEJM, 2000) Medicolegal liability Inappropriate Admissions Inefficient resource utilization Major expense to system
  • 7. Evaluation of Low Risk Patients Presenting to ED with Chest Pain • Goal is to exclude ACS • Not to exclude CAD! • We treat patients, not anatomy
  • 8. Evaluation of Low Risk Patients Presenting to ED with Chest Pain • Magnitude of the problem • Low and intermediate risk • “Confirmatory” tests • CPU and accelerated diagnostic protocols
  • 9. Low Risk in Patients Presenting to the ED with Chest Pain <5% Probability of ACS –History – Typical or atypical CP –Exam – Clinically stable –ECG – Normal (or unchanged) (Negative injury markers greatly risk) Intermediate risk: >65 yo, CAD, DM. CRI
  • 10. Low Risk Is Not No Risk “Confirmatory” test to further reduce risk Nothing is 0%, Nothing is 100%
  • 11. Evaluation of Low Risk Patients • Magnitude of the problem • Low and intermediate risk • Confirmatory tests • CPU and accelerated diagnostic protocols
  • 13. “Confirmatory” Tests • One size does not fit all • Multiple approaches to the problem • Test selection based on institutional expertise, resources, preference
  • 14. Scientific Statement of the American Heart Association
  • 15. “Confirmatory” Tests • Functional Neg. Predictive Value – Treadmill Ex >99% – MPS(sestamibi, stress) >99% – Stress Echo ~95% • Anatomic – CTCA >99% – (MRI) • No Test? >99%
  • 16. Evaluation of Low Risk Patients • Magnitude of the problem • Low and intermediate risk • Confirmatory tests • CPU and accelerated diagnostic protocols
  • 17. Chest Pain Unit • Physical structure • “Virtual” Unit (UCDMC) –Accelerated diagnostic protocol (ADP) • Serial ECGs • cardiac injury markers • LOS 2-6 hrs
  • 18. Accelerated Diagnostic Protocol ED Clinically Stable Negative ECG/Markers Low Risk CPU
  • 19. Accelerated Diagnostic Protocol CPU Serial ECGs, Markers (1-2 sets) To exclude ischemia/necrosis at rest
  • 20. Accelerated Diagnostic Protocol CPU Serial ECGs, Markers (1-2 sets) if negative “Confirmatory” test
  • 21. Accelerated Diagnostic Protocol CPU Serial ECGs, Markers (1-2 sets) if negative Confirmatory test To exclude inducible ischemia or anatomic CAD
  • 22. Accelerated Diagnostic Protocol CPU Serial ECGs, Markers (1-2 sets) if negative Confirmatory test if negative if positive Discharge Admit w/follow-up
  • 23. UCDMC CPU • 17 years, >6,000 patients – Elderly/young, M/F, +/- CAD, antianginal drugs, DM – TIMI risk score not applied in CPU patients • ACC/AHA guidelines – ETT • If ECG WNL and patient can exercise • 1/3 patients require a different test • Preferred initial test at many centers - MPS, CTCA based on expertise, resources
  • 24. ADP in Low Risk Women Presenting with CP • N = 371 • <50 yo, no DM/smoking, • ED ECG normal, clinically stable, neg. markers • ETT = 240, Stress imaging = 20, no confirmatory test = 111 • Negative CPU evaluation in all patients, all directly discharged • 5 yr follow-up: 0 cardiac events • Conclusion: All CP patients do not require confirmatory testing
  • 25. No Confirmatory Test • If ECG, Troponin Negative: • UC Davis – 40% of pts discharged without test, LOS <2 hr – NPV 100% at 1 year • Than (Lancet, JACC) 2012 – No Test, LOS 2 hr • TIMI score 0, ECG neg, hs-cTi neg at 0 and 2 hrs. – NPV >99% at 30 days
  • 26. •Age ≥ 65 y TIMI Risk Score for • Age ≥65y •≥ 3 CAD Risk Factors •≥3CAD RFs •Prior Stenosis > 50% •CAD UA/NSTEMI •ST deviation •ST deviation Antman et al JAMA 284: 835, 2000 •≥ Anginal events ≤ 24 h •≥2 angina/24 h •ASAin last 7 7 d. •ASA in last days •Elev Cardiac Markers •↑ Markers DI/MI/Urg Revasc 50 40.9 40 26.2 30 19.9 (%) 20 8.3 13.2 4.7 10 0 0/1 2 3 4 5 6/7 Number of Risk Factors % Population 4.3 17.3 32.0 29.3 13.0 3.4
  • 27. “Confirmatory” Tests • Functional Neg. Predictive Value – Treadmill Ex >99% – MPS(sestamibi, stress) >99% – Stress Echo ~95% • Anatomic –CTCA >99% • No Test >99%
  • 28.
  • 29. ROMICAT ED ETT – 99% NPV Discharge in <6 hr. Cost $1200 (UCDMC) 38% of patients did not qualify for CTCA Schlett et al, JACCi 2011;4:461
  • 30. CTA in the ED • 12 studies (2005-2012) • N = 5865 pts, 30-81 y.o. • NPV 96-100% (ED and >1 yr) • PPV 13-87% • LOS 7-21 hrs • Radiation 5-18 mSv
  • 31. Radiation • 10-20 mSv exposure = 1 new Ca for every 500-1000 scans • US National Research Council on ionizing radiation (2005)
  • 32. Revascularization after CTA for Low Risk ED CP Patients (Positive Predictive Value 13-87%) Std Care (%) CTA (%) Goldstein 1.0 5.0 CT-STAT 2.4 3.6 Litt 1.3 2.7 ROMICAT-II 4.2 6.4
  • 33. CTA in ED – Exclusions CTA ETT CAD- h/o MI, PCI or CABG YES NO CKD YES NO COPD YES NO Allergy to contrast/ shellfish YES NO > 6 hrs since presentation to ED YES NO BMI ≥39 kg/m 2 YES NO Metformin therapy YES NO Contraindication to β-blocker YES NO Inability to hold breath YES NO Pregnancy YES NO CT imaging within past 48 hours YES NO Normal CTA/cor angiography in previous year YES NO Cocaine use within past 48 hours YES NO Radiographic abnormalities YES NO HR >90 bpm** YES NO
  • 34. CTA in ED Exclusions 12% 50% 46% 52% (More than half of studies do not include % exclusions) Standard of Care?
  • 35. CTA for Chest Pain Patients in the ED The gold standard OR… The Midas touch?
  • 36. Summary • Low/interm risk - ID on presentation • Goal – Exclude ACS (not exclude CAD) • Evaluation - ADP, Confirmatory test • All patients do not require confirmatory test • CTCA – Selected patients only!